VJHemOnc is committed to improving our service to you

COMy 2019 | Lenalidomide for smoldering myeloma

VJHemOnc is committed to improving our service to you

Vincent Rajkumar

Vincent Rajkumar, MD, of the Mayo Clinic, Rochester, MN, gives an insight on the results presented at ASCO 2019 from the largest randomized controlled study in smoldering multiple myeloma looking at lenalidomide vs. observation ECOG-E3A06 (NCT01169337), and comparing these results with those from a past Spanish trial. Talking at the Controversies in Multiple Myeloma (COMy) 2019 meeting held in Paris, France, Dr Rajkumar highlights the positive results that they have found.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter